Inhibition of development, swarming differentiation and virulence factors in Proteus mirabilis by an extract of Lithrea molleoides and its active principle (Z,Z)-5-(trideca-4’,7’-dienyl)-resorcinol
Antibacterial activity of Lithrea molleoides extract against Proteus mirabilis has been previously reported by our group. In the present study, the compound (Z,Z)-5-(trideca-4’,7’-dienyl)-resorcinol ( 1) was isolated as its responsible active principle. The effects of the compound obtained and of L....
Gespeichert in:
Veröffentlicht in: | Phytomedicine (Stuttgart) 2011-08, Vol.18 (11), p.994-997 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Antibacterial activity of
Lithrea molleoides extract against
Proteus mirabilis has been previously reported by our group. In the present study, the compound (Z,Z)-5-(trideca-4’,7’-dienyl)-resorcinol (
1) was isolated as its responsible active principle. The effects of the compound obtained and of
L. molleoides extract on
P. mirabilis growth and virulence factors were evaluated.
Compound
1 showed MIC and MBC values of 4000
μg/ml. It was found that the extract, at four times the MIC, produced complete killing of the uropathogen at 2
h from the beginning of the experiment, while the alkylresorcinol, at four times the MIC, produced the same effect after 24
h. Hemolysis was adversely affected in treatments with both products at 8
μg/ml, while hemagglutination was not altered. The whole extract induced complete autoaggregation of
P. mirabilis at 2000
μg/ml, while compound
1 at the same concentration did not show this property. Swarming motility was delayed in treatments with the extract and with
1 at 1000 and 8
μg/ml, respectively, at 8
h from the beginning of the assay. Complete inhibition of the phenomenon was still observed after 24
h when compound
1 was added at 125
μg/ml.
These findings offer the possibility of new classes of antimicrobial medicines to tackle infections caused by
P. mirabilis. |
---|---|
ISSN: | 0944-7113 1618-095X |
DOI: | 10.1016/j.phymed.2011.03.003 |